Drug or diet? new study tests semaglutide against lifestyle changes for PCOS teens
NCT ID NCT03919929
First seen Jan 04, 2026 · Last updated Jun 15, 2026 · Updated 26 times
Summary
This study looked at 60 teenage girls with PCOS, obesity, and fatty liver disease. Half received the drug semaglutide, and the other half followed a special diet for 12 weeks. The goal was to see which approach better reduced liver fat and improved how the body uses insulin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Anshutz Medical Campus/Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.